Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABUS | Common Shares | Options Exercise | $30.8K | +54.9K | $0.56* | 54.9K | Aug 14, 2024 | Direct | F1 | |
transaction | ABUS | Common Shares | Sale | -$32.6K | -8.85K | -16.11% | $3.69 | 46.1K | Aug 14, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABUS | Stock Option (Right to Buy) | Options Exercise | $0 | -54.9K | -100% | $0.00* | 0 | Aug 14, 2024 | Common Shares | 54.9K | $0.56 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Cashless exercise and hold transaction in director stock options due to expire on November 13, 2024, ten years after such options were granted, including the sale of 8,846 of the underlying shares to pay the exercise price. None of the net 46,069 shares were sold. |
F2 | This is a director stock option grant that is fully vested. |